Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Arthritis,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 24/08/2017, Revision: 8, Status: Authorised

Case Medical Research ◽

10.31525/cmr-399766 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Idacio, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Hidradenitis Suppurativa,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-105efa3 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Arthritis,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 24/08/2017, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-587207 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Idacio, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Hidradenitis Suppurativa,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-106e821 ◽

2019 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Amsparity, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Colitis, Ulcerative,Crohn Disease,Hidradenitis Suppurativa, Date of authorisation: 13/02/2020, Status: Authorised

Case Medical Research ◽

10.31525/cmr-29603ff ◽

2020 ◽

Author(s):

Keyword(s):

Rheumatoid Arthritis ◽

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Cyltezo, adalimumab, Hidradenitis Suppurativa,Arthritis, Psoriatic,Psoriasis,Crohn Disease,Arthritis, Juvenile Rheumatoid,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing, Date of authorisation: 10/11/2017, Revision: 2, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-39974b ◽

2019 ◽

Author(s):

Keyword(s):

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Hulio, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 16/09/2018, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b969c1 ◽

2019 ◽

Author(s):

Keyword(s):

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Cyltezo, adalimumab, Hidradenitis Suppurativa,Arthritis, Psoriatic,Psoriasis,Crohn Disease,Arthritis, Juvenile Rheumatoid,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing, Date of authorisation: 10/11/2017, Revision: 2, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-58720a ◽

2019 ◽

Author(s):

Keyword(s):

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Hyrimoz, adalimumab, Hidradenitis Suppurativa,Crohn Disease,Arthritis, Juvenile Rheumatoid,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing,Skin Diseases, Papulosquamous,Arthritis, Psoriatic, Date of authorisation: 26/07/2018, Revision: 4, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871d9 ◽

2019 ◽

Author(s):

Keyword(s):

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Skin Diseases ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Hulio, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 16/09/2018, Revision: 1, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b9c423 ◽

2019 ◽

Author(s):

Keyword(s):

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text

Human medicines European public assessment report (EPAR): Solymbic, adalimumab, Arthritis, Psoriatic,Spondylitis, Ankylosing,Crohn Disease,Colitis, Ulcerative,Hidradenitis Suppurativa,Psoriasis,Arthritis, Rheumatoid, Date of authorisation: 22/03/2017, Revision: 2, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-cd9d6a ◽

2019 ◽

Author(s):

Keyword(s):

Crohn Disease ◽

Hidradenitis Suppurativa ◽

Assessment Report ◽

Psoriasis Arthritis ◽

European Public ◽

European Public Assessment Report ◽

Colitis Ulcerative ◽

Spondylitis Ankylosing ◽

Arthritis Rheumatoid

Download Full-text